Literature DB >> 12794141

Structure-function relationships of human C5a and C5aR.

Markus S Huber-Lang1, J Vidya Sarma, Stephanie R McGuire, Kristina T Lu, Vaishalee A Padgaonkar, Ellen M Younkin, Ren Feng Guo, Christian H Weber, Erik R Zuiderweg, Firas S Zetoune, Peter A Ward.   

Abstract

Using peptides that represent linear regions of the powerful complement activation product, C5a, or loops that connect the four alpha helices of C5a, we have defined the ability of these peptides to reduce binding of (125)I-C5a to human neutrophils, inhibit chemotactic responses of neutrophils to C5a, and reduce H(2)O(2) production in neutrophils stimulated with PMA. The data have defined likely sites of interaction of C5a with C5aR. The peptides had no functional activity per se on neutrophils and did not interfere with neutrophil responses to the unrelated chemotactic peptide, N-formyl-Met-Leu-Phe. Although previous data have suggested that there are two separate sites on C5a reactive with C5aR, the current data suggest that C5a interacts with C5aR in a manner that engages three discontinuous regions of C5a.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12794141     DOI: 10.4049/jimmunol.170.12.6115

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

Review 1.  Complement activation, regulation, and molecular basis for complement-related diseases.

Authors:  Goran Bajic; Søren E Degn; Steffen Thiel; Gregers R Andersen
Journal:  EMBO J       Date:  2015-10-21       Impact factor: 11.598

Review 2.  The harmful role of c5a on innate immunity in sepsis.

Authors:  Peter A Ward
Journal:  J Innate Immun       Date:  2010-06-26       Impact factor: 7.349

3.  A single functional group substitution in c5a breaks B cell and T cell tolerance and protects against experimental arthritis.

Authors:  Christoph Kessel; Kutty S Nandakumar; Francis B Peters; Varun Gauba; Peter G Schultz; Rikard Holmdahl
Journal:  Arthritis Rheumatol       Date:  2014-03       Impact factor: 10.995

4.  A kinetic model for calcium dynamics in RAW 264.7 cells: 1. Mechanisms, parameters, and subpopulational variability.

Authors:  Mano Ram Maurya; Shankar Subramaniam
Journal:  Biophys J       Date:  2007-05-04       Impact factor: 4.033

5.  Molecular analysis of the bovine anaphylatoxin C5a receptor.

Authors:  Sailasree Nemali; Daniel W Siemsen; Laura K Nelson; Peggy L Bunger; Craig L Faulkner; Pascal Rainard; Katherine A Gauss; Mark A Jutila; Mark T Quinn
Journal:  J Leukoc Biol       Date:  2008-05-14       Impact factor: 4.962

6.  Molecular and expression analysis of complement component C5 in the nurse shark (Ginglymostoma cirratum) and its predicted functional role.

Authors:  Matthew Graham; Dong-Ho Shin; Sylvia L Smith
Journal:  Fish Shellfish Immunol       Date:  2009-05-03       Impact factor: 4.581

7.  New developments in C5a receptor signaling.

Authors:  J Vidya Sarma; Peter A Ward
Journal:  Cell Health Cytoskelet       Date:  2012-07-31

Review 8.  Complement System Part I - Molecular Mechanisms of Activation and Regulation.

Authors:  Nicolas S Merle; Sarah Elizabeth Church; Veronique Fremeaux-Bacchi; Lubka T Roumenina
Journal:  Front Immunol       Date:  2015-06-02       Impact factor: 7.561

9.  Structure and characterization of a high affinity C5a monoclonal antibody that blocks binding to C5aR1 and C5aR2 receptors.

Authors:  Caroline S Colley; Bojana Popovic; Sudharsan Sridharan; Judit E Debreczeni; David Hargeaves; Michael Fung; Ling-Ling An; Bryan Edwards; Joanne Arnold; Elizabeth England; Laura Eghobamien; Ulf Sivars; Liz Flavell; Jonathan Renshaw; Kate Wickson; Paul Warrener; Jingying Zha; Jessica Bonnell; Rob Woods; Trevor Wilkinson; Claire Dobson; Tristan J Vaughan
Journal:  MAbs       Date:  2017-10-24       Impact factor: 5.857

10.  C5a receptor (CD88) promotes motility and invasiveness of gastric cancer by activating RhoA.

Authors:  Takayoshi Kaida; Hidetoshi Nitta; Yuki Kitano; Kensuke Yamamura; Kota Arima; Daisuke Izumi; Takaaki Higashi; Junji Kurashige; Katsunori Imai; Hiromitsu Hayashi; Masaaki Iwatsuki; Takatsugu Ishimoto; Daisuke Hashimoto; Yoichi Yamashita; Akira Chikamoto; Takahisa Imanura; Takatoshi Ishiko; Toru Beppu; Hideo Baba
Journal:  Oncotarget       Date:  2016-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.